NY A 6087
in committeeRequires health insurance policies to fully cover multi-marker testing related to certain patients
New York · 2025-2026 Regular Session · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did NY A 6087 pass?
Not yet. NY A 6087 is in committee and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO INSURANCE
What is NY A 6087 about?
Requires health insurance policies to fully cover multi-marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.
Who sponsors NY A 6087?
Pamela J. Hunter is the primary sponsor of NY A 6087, joined by 1 cosponsor.
Description
Requires health insurance policies to fully cover multi-marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.
- Introduced
- —
- Latest action
- 2026-01-07 — REFERRED TO INSURANCE
- Bill type
- bill
- Last updated
- —
Sponsors
- Pamela J. Hunterprimary
- Tommy Schiavonicosponsor
Committees
Not provided by source.
Action timeline
Newest first
2026-01-07
REFERRED TO INSURANCE
referral-committee
2025-02-26
REFERRED TO INSURANCE
referral-committee
Versions
- A6087Compare
Documents
Votes
Not provided by source.
Related bills
- Prior session: A 6186not in this corpus
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 6087. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.